BXP vs COLL · rev $3.48B vs P/E 17, rev $181.9M
Boston Properties Inc (BXP) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BXP currently screens at market cap $12.12B. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BXP and COLL stock pages for the full models.
Not investment advice.